The 2 analysts offering 12-month price forecasts for vTv Therapeutics Inc have a median target of 6.75, with a high estimate of 7.50 and a low estimate of 6.00. The median estimate represents a +359.18% increase from the last price of 1.47.
The current consensus among 2 polled investment analysts is to Buy stock in vTv Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.07
Reporting Date Nov 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.